Help Make Affordable Insulin a Reality
As part of the Inflation Reduction Act, President Biden signed a historic provision that caps what seniors on Medicare pay for insulin to $35 per month. As you know, this accomplishment has been years in the making, driven by the American Diabetes Association’s (ADA’s) leadership on the issue of insulin affordability and lower out-of-pocket costs. In the weeks leading up to this vote, more than 71,000 advocates reached out to their representatives and senators through the ADA’s Advocacy Engagement Platform. We greatly appreciate you raising your voices in support of passing the first national insulin co-pay cap.
As happy as we are about this historic news, we are extremely disappointed the Senate did not cap monthly co-pays on insulin in commercial plans. The cost of insulin has become out of reach for too many people with diabetes and our work is not over until we make insulin affordable for all people who rely on it to live.
In the meantime, we have created What You Need to Know: Important Information about the Inflation Reduction Act (PDF). This resource provides information about the new Medicare insulin co-pay cap, a provision that sets an annual out-of-pocket maximum for prescription drugs for Medicare beneficiaries, and an extension of current health insurance subsidies for individuals and families through 2025.
